March 2025
Assessment of post adverse drug reactions outcome among people living with HIV/AIDS at level 3 health facilities in Nairobi County
The use of antiretroviral drugs (ARVs) in people living with HIV/AIDS (PLHIV) has led to the occurrence of adverse drug reactions (ADRs), which are defined by the WHO as any unintended or excessive response to a drug. ADRs are influenced by both the impact of the disease on the immune system and the safety profile of ARVs. Pharmacovigilance is crucial in identifying and preventing such ADRs. The present study aims to...
March 2025
Unveiling gender disparities and State dynamics in HIV viral suppression: Insights from Southern Nigeria
This study aimed to elucidate gender disparities and state dynamics in HIV viral suppression within the context of Southern Nigeria, as part of the USAID-funded project "Accelerating Control of the HIV/AIDS Epidemic in Nigeria, Cluster 6" (ACE 6). The study employed an ex post facto research design and used multiple logistic regressions to analyze patient-level data for active Peo ple Living with HIV (PLHIV)...
March 2025
CD4 T-Lymphocytes, adherence and sociodemographic factors associated with viral load outcome of people living with HIV (PLHIV) on antiretroviral therapy in Lagos State, Nigeria
Globally, a significant number of people were living with HIV in 2022, with a substantial proportion receiving antiretroviral therapy (ART). Despite these advancements, HIV continues to pose a serious challenge to global health. Against this backdrop, this study evaluated CD4 T-lymphocytes, adherence, and sociodemographic factors associated with the current viral load outcome of People Living with HIV (PLHIV) on ART in...
Advertisement
Advertisement